Literature DB >> 28836584

Iron dysregulates APP processing accompanying with sAPPα cellular retention and β-secretase inhibition in rat cortical neurons.

Yu-Ting Chen1,2, Wu-Yan Chen1, Xiao-Tian Huang1, Ye-Chun Xu1, Hai-Yan Zhang1,3.   

Abstract

Amyloid precursor protein (APP) and iron both play pivotal roles in the central nervous system, but whether and how iron influences the processing of endogenous APP in neurons remain unclear. Here, we investigated the regulatory effects and underlying mechanisms of iron on non-amyloidogenic and amyloidogenic processing of APP in rat primary cortical neurons. Treatment of the neurons with ferric ammonium citrate (FAC, 100 μmol/L) markedly facilitated the non-amyloidogenic processing of APP, as evidenced by a robust increase in α-secretase-derived carboxy-terminal fragment α (CTFα). Furthermore, the distribution of sAPPα was altered after iron treatment, and sAPPα remained in the cellular lysates instead of being secreted into the extracellular milieu. Moreover, the levels of APP amyloidogenic products, including sAPPβ and Aβ were both decreased. We further revealed that FAC did not alter the expression of β-secretase, but significantly suppressed its enzymatic activity in iron-treated neurons. In a cell-free β-secretase activity assay, FAC dose-dependently inhibited the activity of purified β-secretase with an IC50 value of 21.67 μmol/L. Our data provide the first evidence that iron overload alters the neuronal sAPPα distribution and directly inhibits β-secretase activity. These findings shed light on the regulatory mechanism of bio-metals on APP processing.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28836584      PMCID: PMC5800463          DOI: 10.1038/aps.2017.113

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  49 in total

1.  The production of amyloid beta peptide is a critical requirement for the viability of central neurons.

Authors:  Leigh D Plant; John P Boyle; Ian F Smith; Chris Peers; Hugh A Pearson
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

2.  Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.

Authors:  L Devi; M Ohno
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

3.  A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload.

Authors:  Jirapas Sripetchwandee; Suwakon Wongjaikam; Warunsorn Krintratun; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Neuroscience       Date:  2016-07-09       Impact factor: 3.590

4.  Cleavage of Alzheimer's amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells.

Authors:  S Parvathy; I Hussain; E H Karran; A J Turner; N M Hooper
Journal:  Biochemistry       Date:  1999-07-27       Impact factor: 3.162

5.  Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder.

Authors:  Joel Jakobsson; Henrik Zetterberg; Kaj Blennow; Carl Johan Ekman; Anette G M Johansson; Mikael Landén
Journal:  Neuropsychopharmacology       Date:  2012-11-06       Impact factor: 7.853

6.  Multiple mechanisms of iron-induced amyloid beta-peptide accumulation in SHSY5Y cells: protective action of negletein.

Authors:  Priyanjalee Banerjee; Arghyadip Sahoo; Shruti Anand; Anirban Ganguly; Giuliana Righi; Paolo Bovicelli; Luciano Saso; Sasanka Chakrabarti
Journal:  Neuromolecular Med       Date:  2014-09-24       Impact factor: 3.843

7.  An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.

Authors:  Jack T Rogers; Jeffrey D Randall; Catherine M Cahill; Paul S Eder; Xudong Huang; Hiromi Gunshin; Lorene Leiter; Jay McPhee; Satinder S Sarang; Tada Utsuki; Nigel H Greig; Debomoy K Lahiri; Rudolph E Tanzi; Ashley I Bush; Tony Giordano; Steve R Gullans
Journal:  J Biol Chem       Date:  2002-08-26       Impact factor: 5.157

8.  In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan.

Authors:  Julio Acosta-Cabronero; Matthew J Betts; Arturo Cardenas-Blanco; Shan Yang; Peter J Nestor
Journal:  J Neurosci       Date:  2016-01-13       Impact factor: 6.167

9.  β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin.

Authors:  Bruce X Wong; Andrew Tsatsanis; Linh Q Lim; Paul A Adlard; Ashley I Bush; James A Duce
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

10.  Altered APP Carboxyl-Terminal Processing Under Ferrous Iron Treatment in PC12 Cells.

Authors:  Chi Hyun Kim; Yeong-Min Yoo
Journal:  Korean J Physiol Pharmacol       Date:  2013-06-11       Impact factor: 2.016

View more
  7 in total

1.  Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer's Disease.

Authors:  Amanda L Lumsden; Jack T Rogers; Shohreh Majd; Morgan Newman; Greg T Sutherland; Giuseppe Verdile; Michael Lardelli
Journal:  Front Neurosci       Date:  2018-08-13       Impact factor: 4.677

Review 2.  Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration.

Authors:  Shalini S Rao; Paul Anthony Adlard
Journal:  Front Mol Neurosci       Date:  2018-08-17       Impact factor: 5.639

3.  Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease.

Authors:  Balmiki Ray; Bryan Maloney; Kumar Sambamurti; Hanuma K Karnati; Peter T Nelson; Nigel H Greig; Debomoy K Lahiri
Journal:  Transl Psychiatry       Date:  2020-02-03       Impact factor: 6.222

Review 4.  Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.

Authors:  Cadiele Oliana Reichert; Fábio Alessandro de Freitas; Juliana Sampaio-Silva; Leonardo Rokita-Rosa; Priscila de Lima Barros; Debora Levy; Sérgio Paulo Bydlowski
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 5.  Iron and Alzheimer's Disease: From Pathology to Imaging.

Authors:  Dean Tran; Phillip DiGiacomo; Donald E Born; Marios Georgiadis; Michael Zeineh
Journal:  Front Hum Neurosci       Date:  2022-07-13       Impact factor: 3.473

Review 6.  Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications.

Authors:  Jun-Lin Liu; Yong-Gang Fan; Zheng-Sheng Yang; Zhan-You Wang; Chuang Guo
Journal:  Front Neurosci       Date:  2018-09-10       Impact factor: 4.677

Review 7.  The essential elements of Alzheimer's disease.

Authors:  Peng Lei; Scott Ayton; Ashley I Bush
Journal:  J Biol Chem       Date:  2020-11-27       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.